glp 1 agonists and sglt2 inhibitors Criteria for recommendation of or GLP-1 receptor GLP-1 Agonists vs. SGLT2 Inhibitors:
Description
10.1111/jdi.12956 127 YingX.RongjiongZ.KahaerM.ChunhuiJ.WulasihanM

Teladoc Health care providers can prescribe GLP-1 medications for weight loss when clinically appropriate and permitted by state regulations

Piening A, Ebert E, Gottlieb C, Khojandi N, Kuehm LM, Hoft SG, et al

Tirzepatides May 13, 2022 approval as Mounjaro for type 2 diabetes introduced the first dual GIP/GLP 1 receptor agonist, producing unprecedented weight loss

Tirzepatide achieved significant reductions in Glycated Hemoglobin A1c (HbA1c) levels and body weight compared to placebo

So what are obesity phenotypes
